Trial
NCT03760614
A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
Syndax Pharmaceuticals
Condition
Pancreas Cancer
Intervention
Entinostat
Why stopped
Lack of Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-15